Navigation Links
Genomic Health Announces Oncotype DX(R) Provides Additional Prognostic Benefit in Patients Assessed With Adjuvant Online
Date:12/15/2007

udy found that the Recurrence Score result was a highly significant predictor of recurrence in both node-negative disease (p=0.0007) and node-positive disease (p=0.0004). In addition, a low Recurrence Score result predicted a low likelihood of recurrence regardless of nodal status.

"In examining the relationship between the Oncotype DX Recurrence Score and Adjuvant Online, we found that both tools have value in providing crucial information on the likelihood of breast cancer recurrence," said Peter Ravdin, M.D., Ph.D., the M.D. Anderson Cancer Center physician who developed the Adjuvant Online tool and a co-author of the study. "Specifically, the addition of Oncotype DX Recurrence Score results yielded supplementary insight on outcomes for breast cancer patients. Used together, we have the opportunity to more effectively guide personal treatment decisions based on a woman's individual breast cancer."

About Oncotype DX(R)

Oncotype DX is the first diagnostic multi-gene expression test commercially available that has clinical evidence validating its ability to predict the likelihood of breast cancer recurrence, the likelihood of breast cancer survival and the likelihood of chemotherapy benefit. Oncotype DX has been extensively evaluated in multiple independent studies involving more than 3,300 breast cancer patients, including a large validation study published in The New England Journal of Medicine and a chemotherapy benefit study published in the Journal of Clinical Oncology. To date, nearly 7,000 physicians have ordered more than 40,000 tests, and health plans covering over 50 percent of U.S. insured lives provide reimbursement for Oncotype DX through contracts, agreements and policy decisions. The American Society of Clinical Oncologists (ASCO) recommends the use of Oncotype DX for patients with node-negative breast cancer that is estrogen-receptor positive and/or progesterone-receptor positive. For more information about Oncotype DX, please vi
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Microarray provides 3 genomic guides to breast cancer treatment decisions
3. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
4. Genomic Health to Present at ThinkEquity Partners Fifth Annual Growth Conference
5. Genomic profiling of lung tumors helps doctors choose most effective treatment
6. Genomic technologies to identify toxic chemicals should be developed
7. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
8. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
9. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
10. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
11. Genomic Health to Present at JMP Securities Healthcare Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... A Bakersfield, Calif. state court jury returned a verdict ... plaintiff Coleen M. Perry a total of $5.7 million for ... mesh sling device, manufactured by Ethicon, Inc., a subsidiary of ... at Wagstaff & Cartmell in Kansas City, Mo., ... Rich Freese and Tim Goss of Freese & Goss ...
(Date:3/5/2015)... March 05, 2015 Central Nebraska Imaging ... practice including the brand’s new logo and optimized website. ... the practice’s modern approach to expert diagnostic imaging, centered ... and be built to be a resource for Nebraska ... With automated forms, communication and referral functionality, video content ...
(Date:3/5/2015)... CA (PRWEB) March 05, 2015 On ... titled “Butt Augmentation, Labiaplasty on the Rise, Plastic Surgeons ... by the American Society for Aesthetic Plastic Surgery ... . Both groups reported a year-over-year doubling of surgical ... the physicians quoted in the article, this increase can ...
(Date:3/5/2015)... At the 7th Annual Mississippi ... addiction treatment met today in Jackson, Mississippi to listen ... Among the numerous respected speakers will be William ... role that pain medications have had in today’s opiate ... , "It is hard to believe that much of ...
(Date:3/5/2015)... March 05, 2015 University of ... founded in 1904, has launched a new center ... lifestyle changes. The Northwest Center for Lifestyle and ... support community outreach, and conduct research in the ... diet and nutrition. The center will target efforts ...
Breaking Medicine News(10 mins):Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3Health News:University of Western States Launches Northwest Center for Lifestyle and Functional Medicine 2
... Prostatitis is a common,problem, yet the antibiotics physicians ... associated with this condition work in only a ... condition have a form called,chronic nonbacterial prostatitis, which ... edition of Harvard Medical School,s Perspectives on Prostate,Disease ...
... psychiatric nurses believe that people with Borderline Personality Disorder (BPD) ... adults suffer from the condition, according to the October issue ... Ninety-eight per cent of nurses said service shortages played a ... disagreements between staff on how to care for people with ...
... York, NYHealth insurance reform plans that build on a ... are shared among government, employers, and enrollees would have ... and would be the most practical to implement according ... Fund Commission on a High Performance Health System. Commissioners ...
... ... By Dana Ullman, MPH Foreword by Dr. Peter Fisher ... There is a good reason that 11,American presidents, 7 popes, Charles Darwin, ... for,homeopathic treatment: homeopathy works! The majority of people in Western society ...
... PHOENIX, Oct. 17, 2007 Two Arizona-based philanthropic ... innovative initiative to develop personalized molecular diagnostics. The ... every persons unique physiological makeup is critical to ... the same time reducing medical costs. , ...
... Onco-genomic guided trial design may increase probability of tumor response ... and ... Inc.,(CTI) (Nasdaq and MTAX: CTIC) and Systems Medicine, LLC (SM), ... first,patient to its complete phase Ib trial of brostallicin used ...
Cached Medicine News:Health News:Antibiotics May Not Help Men's Chronic Pelvic Pain: Harvard Doctors Discuss Alternatives 2Health News:Services for patients with BPD need to be improved say psychiatric nurses 2Health News:Services for patients with BPD need to be improved say psychiatric nurses 3Health News:New report: private/public insurance mix is most practical way to achieve universal coverage 2Health News:New report: private/public insurance mix is most practical way to achieve universal coverage 3Health News:New report: private/public insurance mix is most practical way to achieve universal coverage 4Health News:The Homeopathic Revolution 2Health News:The Homeopathic Revolution 3Health News:Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative 2Health News:Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative 3Health News:Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative 4Health News:U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors 2Health News:U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors 3Health News:U.S. Oncology Initiates Complete Phase Ib Trial of Brostallicin Combination Therapy in Advanced Solid Tumors 4
(Date:3/5/2015)... MOUNTAIN VIEW, Calif., March 5, 2015  IRIDEX Corporation (Nasdaq: ... fourth quarter and year ended January 3, 2015.  ... 2014, a record for the Company and up 11% from ... were $42.8 million, also a record, up 12% from $38.3 ... fourth quarter was 50.1%, up from 48.6% in the fourth ...
(Date:3/5/2015)... Bayer HealthCare announced today that it has ... of the American Society of Clinical Oncology (ASCO) to ... designed to unlock vast quantities of information about the ... "Bayer is proud to join ASCO and the Conquer ... to help people whose lives have been affected by ...
(Date:3/5/2015)... , March 5, 2015   AMC ... management solutions recognized for improving the effectiveness and ... that Robert Anazagasty and Jared ... serve as Vice President, Strategic Client Development, and ... These additions support AMC Health,s commitment to accelerating ...
Breaking Medicine Technology:IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 2Bayer HealthCare Contributes $1 Million to Support Cancer Care Technology Platform 3AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 2AMC Health Bolsters Sales Team with Robert Anazagasty and Jared Wilstead 3
... Particle Sciences Inc. (PSI), a leading pharmaceutical ... supplier of ethylene vinyl acetate (EVA) into pharmaceutical ... of drug-eluting devices.  Building on years of collaboration, ... working to provide Particle Sciences with preferred access ...
... IRIDEX Corporation (NASDAQ: IRIX ) today announced that it ... closes on Thursday, May 5, 2011.  In ... with the investment community at 5:00 p.m. Eastern Time ... to discuss the results of the quarter and other business developments. ...
Cached Medicine Technology:Particle Sciences and Celanese EVA Performance Polymers Collaborate to Accelerate Drug-Eluting Device Combinations 2Particle Sciences and Celanese EVA Performance Polymers Collaborate to Accelerate Drug-Eluting Device Combinations 3
... Eyes enzymatic cleaner is a ... removes stubborn deposits in as ... eyes enzymatic cleaner contains an ... irritating film on soft contact ...
... These specialty Eraser instruments have been ... with the right tool for situations ... a series of 25 gauge intraocular, ... discrete treatment of target tissues for ...
Wet-Field Hemostatic Eraser bipolar tip, packsize is 10/box....
Titanium. Straight shafts with curved lower tip. Upper tip fits into positioning hole while lower jaw stabilizes the lens. Flat smooth handle with dull finish. Most popular size or model....
Medicine Products: